A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
GOALS: To evaluate the effectiveness of psychiatric counseling in reducing the rate of development of psychiatric side effects of antiviral therapy with interferon-α and ribavirin among study participants compared with standard clinical monitoring alone. BACKGROUND: Interferon-α is used to treat chronic hepatitis C. Interferons may induce adverse events that usually, but not always, reverse within a few days after the end of therapy. STUDY: Two hundred eleven patients with chronic hepatitis C, genotype 1b were treated with peginterferon and ribavirin for 48 weeks in a prospective trial. Two groups were randomly created. Group A was interviewed by a team of gastroenterologists, psychiatrists, and psychologists and treated with psychotherapy once a month. Group B was monitored once a month according to a conventional protocol that did not include psychotherapy. SVR (sustained viral response), severe psychiatric symptom onset, and mood progression were assessed (P calculated using Fisher exact test, Friedman test, Dunn posttest, and Mann-Whitney U-test). RESULTS: At baseline, there was no difference in depressive symptoms or liver histologic score between the 2 groups. The onset rate of severe psychiatric manifestations was 4.7% (Group A) and 16.1% (Group B) between the 24th and 36th weeks (P<0.01). Fifteen participants in Group A and 39 in Group B required antidepressants and benzodiazepines (P<0.05). CONCLUSIONS: Patients can develop depressive symptoms during interferon therapy. Multidisciplinary medical treatment with psychiatric counseling provided during the treatment of chronic hepatitis C may contribute to the decrease or prevent the higher rates of depression associated with interferon treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“for the strikingly high rates of depression accompanying hepatitis C, only Level 3 Evidence exists for psychological treatments”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [35]
Citations
Cites
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Classification of chronic viral hepatitis: a need for reassessment
Scheuer, P. J. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90084-o · Cited by 1,576 · cited 1×
“The inflammatory activity (grading 1 to 4, score G1 to G4) and degree of fibrosis (staging 1 to 4 score S1 to S4) were assessed on the biopsy specimens according to Scheuer numerical score.(19) After the liver biopsy, participants were randomly assigned to Groups A and B in a 1:1 ratio from a computer generated list u…”
MethodHepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Fattovich, G., Giustina, G., Favarato, S., & Ruol, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80184-x · Cited by 489
Induction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants
Peet, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.4.549 · Cited by 474
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Dieperink, E., Willenbring, M., & Ho, S. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.867 · Cited by 422
Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction
Raison, C. L., Borisov, A. S., Broadwell, S. D., Capuron, L., Woolwine, B. J., Jacobson, I. M., Nemeroff, C. B., & Miller, A. H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0106 · Cited by 299
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., & Maes, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00264-1 · Cited by 284
Treatment of Hepatitis C Infection in Injection Drug Users
Backmund, M., Meyer, K., Von Zielonka, M., & Eichenlaub, D. (2001) · Hepatology · doi:10.1053/jhep.2001.25882 · Cited by 256
Psychiatric Symptoms in Patients With Chronic Hepatitis C Receiving Interferon Alfa-2b Therapy
Kraus, M. R., Schafer, A., Faller, H., Csef, H., & Scheurlen, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0614 · Cited by 245
The phenomenology and treatment of interferon-induced depression
Loftis, J. M., & Hauser, P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.04.002 · Cited by 226
Cognitive-Behavioral Therapy and Psychodynamic Psychotherapy: Techniques, Efficacy, and Indications
Leichsenring, F., Hiller, W., Weissberg, M., & Leibing, E. (2006) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.2006.60.3.233 · Cited by 182
Maddrey, W. C. (1999) · PubMed · Cited by 158
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149 · cited 1×
“Various neuropsychiatric side effects have been attributed to IFN-a, including a pattern of subcortical cognitive impairment.(29) Symptoms include decreased motivation, increased apathy, impaired executive function, and memory loss.”
BackgroundSchaefer, M., Hinzpeter, A., Mohmand, A., Janssen, G., Pich, M., Schwaiger, M., Sarkar, R., Friebe, A., Heinz, A., Kluschke, M., et al. (2007) · Hepatology · doi:10.1002/hep.21791 · Cited by 142 · cited 1×
“In addition, some cases(9) of suicidal ideation have been reported in patients with chronic hepatitis C during treatment with interferon and even after treatment.(10) In contrast, several studies(8,11,12) have shown that patients with hepatitis C infection have high rates of both current and past psychiatric disturban…”
ResultHorikawa, N., Yamazaki, T., Izumi, N., & Uchihara, M. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00239-6 · Cited by 140
Knott, A., Dieperink, E., Willenbring, M. L., Heit, S., Durfee, J. M., Wingert, M., Johnson, J. R., Thuras, P., & Ho, S. B. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00731.x · Cited by 128
Pegylated interferons: chemical and clinical differences
Foster, G. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02170.x · Cited by 110
Psychological Disorders and Distress After Adult Cardiothoracic Transplantation
Dew, M. A., & DiMartini, A. F. (2005) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200509001-00007 · Cited by 108
Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C
Dieperink, E., Ho, S. B., Tetrick, L., Thuras, P., Dua, K., & Willenbring, M. L. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.01.003 · Cited by 106
Malaguarnera, M., Di Fazio, I., Restuccia, S., Pistone, G., Ferlito, L., & Rampello, L. (1998) · Neuropsychobiology · doi:10.1159/000026485 · Cited by 98
Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment
Bianchi, G. P., Loguercio, C., Sgarbi, D., Abbiati, R. A., Chen, C. H., Pierro, M. D., Disalvo, D., Natale, S., & Marchesini, G. (2000) · Digestive and Liver Disease · doi:10.1016/s1590-8658(00)80260-1 · Cited by 53 · cited 1×
“It is worth remembering how important psychologic counseling could be in chronic hepatitis C patients with compromised mental health; particularly during the course of IFN treatment.(34) Cognitive-behavioral therapy is most useful when used with antidepressants to treat moderate-to-severe depression.”
BackgroundPsychosocial and behavioral interventions for chronic medical conditions
Fekete, E. M., Antoni, M. H., & Schneiderman, N. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280147724 · Cited by 44
Interferon-induced depression: prevalence and management
Scalori, A., Pozzi, M., Bellia, V., Apale, P., Santamaria, G., Bordoni, T., Redaelli, A. E., Avolio, A. W., Parravicini, P., Pioltelli, P. E., et al. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.09.018 · Cited by 41 · cited 1×
“99).(5) The MMPI is a self-evaluation test composed of 566 items that cover an extensive range of behaviors and attitudes.”
BackgroundMarkowitz, J. C., Bleiberg, K. L., Christos, P., & Levitan, E. (2006) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000195314.80210.41 · Cited by 40
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40 · cited 1×
“They often necessitate the discontinuation of therapy and/or the use of psychopharmacologic agents.(13) Substance use and psychiatric comorbidities are common in patients with hepatitis C and psychiatric side effects can deteriorate the compliance of antiviral therapy in these patients.”
BackgroundRamasubbu, R. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00383.x · Cited by 39
Immunological response in chronic hepatitis C virus infection during interferon alpha therapy.
Panasiuk, A., Prokopowicz, D., & Żak, J. (2004) · PubMed · Cited by 7
Vostanis, P. (1994) · The British Journal of Psychiatry · doi:10.1192/s0007125000051552 · Cited by 3
Research works printed but not linked: 2
- 2006, 41th Annual meeting; International Consensus Conference on Hepatitis C. Consensus Statement., J Hepatol, 1, S56
- Hadziannis, 2004, Pegintron alpha 2-a and ribavirin combination therapy in chronic hepatitis C:a randomized study of treatment duration and ribavirin dose., Ann Intern Med, 140, 436
Cited by
Interventions for preventing delirium in hospitalised non-ICU patients
Siddiqi, N., Harrison, J. K., Clegg, A., Teale, E. A., Young, J., Taylor, J., & Simpkins, S. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005563.pub3 · Cited by 619
Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis
Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., Langohr, K., Solà, R., Vieta, E., & Martín-Santos, R. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07694 · Cited by 297
Hayn, M., Hirschenberger, M., Koepke, L., Nchioua, R., Straub, J. H., Klute, S., Hunszinger, V., Zech, F., Prelli Bozzo, C., Aftab, W., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109126 · Cited by 233
“Severe side effects are prevalent during IFN therapy (Fried, 2002; Neri et al., 2010; van Zonneveld et al., 2005).”
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., Foster, G. R., Kautz, A., Forton, D., & Pariante, C. M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.037 · Cited by 225
“A concomitant and continuous psychotherapeutic support programme has recently been shown to be able to reduce acute psychiatric complications and the need for pharmacological interventions during antiviral therapy [92].”
Self-citation
Metadata
- Authors
- Neri, S., Bertino, G., Petralia, A., Giancarlo, C., Rizzotto, A., Calvagno, G. S., Mauceri, B., Abate, G., Boemi, P., Di Pino, A., Ignaccolo, L., Vadalà, G., Misseri, M., Maiorca, D., Mastrosimone, G., Judica, A., & Palermo, F.
- Affiliations
- University of Catania (IT)
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-10
- Volume
- 44
- Issue
- 9
- Pages
- e210-e217
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2330593897
- Semantic Scholar
- 80326e32f2c2d8020f10218dd33cfab311f35f5a
- Cited by
- 37
- References
- 33
- Citations by year
- 2024: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 7 · 2012: 8
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- chronic hepatitis C, pegylated interferon-alpha, ribavirin, psychiatric adverse effects, depression, psychiatric counseling, psychotherapy, multidisciplinary care, antidepressants, benzodiazepines, sustained virological response
- MeSH terms
- Interferon alpha-2, Antiviral Agents, Depression, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Polyethylene Glycols, Prospective Studies, Psychotherapy, Recombinant Proteins, Ribavirin, Severity of Illness Index, Interferon-alpha, Drug Monitoring, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.